Mafosfamide (INN; development code ASTA-Z-7557) is an oxazaphosphorine (cyclophosphamide-like) alkylating agent under investigation as a chemotherapeutic. It is metabolized by cytochrome P450 into 4-hydroxycyclophosphamide, which is then converted into aldophosphamide, which, in turn yields the cytotoxic metabolites phosphoramide mustard and acrolein. Several Phase I trials have been completed.
References
Further reading Prous, J. R. (1983). "ASTA-Z-7557". Drugs of the Future. 8 (10): 839. doi:10.1358/dof.1983.008.10.61900. ISSN 0377-8282.



